Internal Medicine, Endocrinology, Diabetes, & Metabolism · Southfield, MI
NPI
1548581861
Since 2010
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
22255 Greenfield Rd, Suite 400
Southfield, MI, 48075
Phone (248) 849-4880
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
824 services
Medicare patients, 2024
330
Average age 70
Drug cost, 2024
$2.1M
4,051 prescriptions
Company payments, 2025
$302
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jayme A Aschemeyer was code 99214 (office e&m - established), 241 times for 182 patients. In total Jayme A Aschemeyer billed 824 services in 23 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 241 | 182 | $66.34 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 113 | 102 | $12.32 | $1,393 |
| 99214 Office E&M - Established | Office | 84 | 67 | $75.20 | $6,317 |
| 99232 Hospital E&M - Subsequent | Facility | 81 | 45 | $61.80 | $5,006 |
| 95251 Test - Miscellaneous | Facility | 77 | 55 | $24.73 | $1,904 |
| 99223 Hospital E&M - Initial | Facility | 52 | 48 | $124.79 | $6,489 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 51 | 42 | $12.71 | $648 |
| 83036 Blood Count | Office | 26 | 19 | $7.00 | $182 |
| 95251 Test - Miscellaneous | Office | 22 | 17 | $22.66 | $499 |
| 99204 Office E&M - New | Office | 13 | 13 | $115.91 | $1,507 |
| 99204 Office E&M - New | Facility | 13 | 13 | $75.03 | $975 |
By year: 2022 $48K for 716 services; 2023 $46K for 691 services; 2024 $45K for 824 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 26 | 19 | $7.00 | $182 |
Medicare prescription drug claims, 2024
In 2024, the drug Jayme A Aschemeyer prescribed most often to Medicare patients was Levothyroxine Sodium, with 499 prescriptions and refills. In total Jayme A Aschemeyer wrote 4,051 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 499 | 1,382 | 147 | $5,831 |
| Ozempic Semaglutide | 271 | 518 | 70 | $479K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 233 | 660 | 89 | $49K |
| Trulicity Dulaglutide | 225 | 403 | 52 | $381K |
| Metformin Hcl Generic | 217 | 588 | 69 | $2,129 |
| Metformin Hcl Er Metformin Hcl | 194 | 519 | 66 | $3,167 |
| Jardiance Empagliflozin | 193 | 429 | 53 | $236K |
| Mounjaro Tirzepatide | 115 | 188 | 30 | $195K |
| Glimepiride Generic | 96 | 257 | 33 | $1,470 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 93 | 249 | 48 | $10K |
| Novolog Flexpen Insulin Aspart | 92 | 228 | 43 | $32K |
| Atorvastatin Calcium Generic | 84 | 187 | 19 | $1,076 |
| Methimazole Generic | 83 | 238 | 28 | $1,235 |
| Glipizide Er Glipizide | 73 | 207 | 29 | $2,459 |
| Alendronate Sodium Generic | 68 | 162 | 21 | $619 |
Brand drugs: 1,915 claims; generic drugs: 1,737 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jayme A Aschemeyer $302 ($302 in general payments such as food, travel and fees) from 2 companies. The largest payer was Medtronic, Inc. with $281.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 8 | $281 |
| Xeris Pharmaceuticals, Inc. | 1 | $21.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.